Morgan Stanley analyst Keith Weiss raised the firm’s price target on CoreWeave (CRWV) to $58 from $46 and keeps an Equal Weight rating on the shares. CoreWeave’s first quarter out of the gate “gave new talking points to both the bulls and bears,” as the company responds to an “acceleration of customer to demand” with a faster pace of build out of their GenAI infrastructure, the analyst tells investors. While accelerated build-out enabled a large revenue beat in Q1, it also increases interest expense and capex expectations for FY25, pressuring near-term free cash flow, says the analyst, who calls CoreWeave “a solid (long-term) play on an emerging GPU economy.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRWV:
- CoreWeave price target raised to $76 from $42 at BofA
- CoreWeave price target raised to $60 from $50 at Wells Fargo
- CoreWeave, Inc.: Strong Financial Performance and Market Position Justify Buy Rating
- CoreWeave, Inc.: Balancing Impressive Growth with Emerging Financial Risks
- CoreWeave’s Strategic Growth and Strong Q1 Performance Justify Buy Rating and Increased Price Objective